Parkinson’s research with inclusion, diversity and equity (PRIDE): examining Parkinson’s disease symptoms among LGBTQ+ and non-LGBTQ+ adults Authors: Jason Flatt, Brittany Klenczar-Castro, Sydney Kenney, Binita Adhikari, Krystal Kittle, Jennifer Pharr, Erin Rook, Emylia Terry Published: 2026 ABSTRACT IntroductionNearly four million LGBTQ+ adults aged 50 and older live in the U.S., with up to 40,000 currently living with Parkinson’s disease (PD). However, little is known about PD-related symptoms in this population.MethodsFrom 2022 to 2025, we conducted a national cross-sectional study using a convenience sample of LGBTQ+ and non-LGBTQ+ individuals living with PD (n = 254). We administered validated PD and health-related measures to examine physical, mental and social health symptoms. Bivariate and regression models examined differences in symptom burden between LGBTQ+ and non-LGBTQ+ participants, as well as associations with sociodemographic characteristics and social determinants of health.ResultsThe sample included 89 LGBTQ+ and 165 non-LGBTQ+ individuals living with PD. On average, LGBTQ+ participants were 5.3 years younger than their non-LGBTQ+ counterparts (mean age: 62.9 vs. 68.3). Compared with non-LGBTQ+ participants, LGBTQ+ individuals living with PD were more likely to report anxiety (53.9% vs. 33.3%, p = 0.002), moderate-to-severe motor impairments (32.2% vs. 19.4% p = 0.024), and loneliness (18.8% vs. 8.5%, p = 0.037). Regarding social determinants of health, younger age, identifying as a person of color, and experiencing healthcare discrimination were associated with higher odds of reporting moderate-to-severe PD-related symptoms.DiscussionThis study highlights potential disparities in PD-related symptoms, with LGBTQ+ individuals, persons of color, and those experiencing healthcare discrimination being more likely to report physical, mental and social health challenges. There is a need for further research on the health needs of diverse populations living with PD, including LGBTQ+ adults, as well as the development of tailored and inclusive healthcare strategies. Introduction Parkinson’s disease (PD) is the second most common neurodegenerative disorder worldwide, affecting over 6 million people globally, with prevalence projected to more than double by 2050 (1, 2). Although PD is often characterized by motor symptoms such as tremors, rigidity, and gait impairment, non-motor symptoms, including depression, anxiety, sleep disturbances, fatigue, and autonomic dysfunction, are also common and often contribute to disability and reduced quality of life (3, 4). Many individuals living with PD identify non-motor symptoms among their top concerns, highlighting the need to understand both non-motor and motor symptom experiences. Beyond PD-related symptoms, many individuals live with multiple chronic health conditions that can complicate disease management and symptom progression. Comorbidities, such as depression and cardiovascular disease, have been associated with worse motor outcomes, greater cognitive impairment, and increased disability among individuals living with PD (5–7). These findings highlight that PD symptom burden is closely linked to both physical and mental health conditions, which may also influence disease progression and quality of life. The experiences of individuals living with PD are further shaped by social determinants of health, including economic stability, healthcare access, social relationships, and experiences of discrimination. Structural inequities contribute to higher rates of chronic illness and poorer health outcomes among historically marginalized populations, including racial and ethnic minorities, LGBTQ+ individuals, people from lower socioeconomic backgrounds, and those living in rural communities (8, 9). These determinants may create additional barriers to managing PD symptoms, accessing specialty care, and maintaining overall wellbeing. Recent studies suggests that LGBTQ+ individuals living with PD may experience unique challenges related to symptom burden and healthcare access. For instance, studies find that LGBTQ+ individuals with PD report an earlier age of diagnosis, greater disease burden, and more frequent experiences of healthcare discrimination compared with their cisgender, heterosexual counterparts (10, 11). These compounding factors often contribute to worse quality of life for LGBTQ+ individuals living with PD. Improving understanding of symptom experiences among diverse populations is critical for developing more equitable and person-centered approaches to PD care. Despite growing recognition of health disparities among diverse aging populations, relatively little research has examined whether PD symptom burden differs by LGBTQ+ identity. The present study seeks to examine differences in physical, mental and social health symptoms among LGBTQ+ and non-LGBTQ+ individuals living with PD, and to explore social determinants associated with these symptoms. Methods Study design From 2022 to 2025, we conducted an observational, cross-sectional study with a convenience sample of LGBTQ+ and non-LGBTQ+ individuals living with PD and/or their family caregiving via a telephone survey. Participant inclusion criteria were: (1) identified as LGBTQ+ or non-LGBTQ+, (2) 18+ years of age, and (3) had the ability to complete the phone or online survey in English or Spanish. The telephone surveys were developed using computer-assisted telephone interviewing, and trained interviewer conducted the survey by telephone. The one-time survey took up to 45 min to complete. Of the 254 completed surveys, 187 were completed directly by individuals living with PD, whereas 67 were completed by family caregivers serving as proxy respondents on behalf of the individual living with PD. In many of these interviews, the individual living with PD was present during the telephone survey and contributed to the responses. Participants were recruited via print and social media (e.g., The Advocate), through communications with local and national LGBTQ+ organizations (e.g., SAGE, Center Link, LGBTQ+ Centers, Pride Festivals), local and national organizations (e.g., Michael J. Fox Foundation’s Buddy Network, ClinicalTrials.gov, Fox Trial Finder), senior centers, PD support groups and/or exercise groups, webinars, and by asking healthcare providers to distribute the study flyer. Participants received $25 for survey completion. The survey collected demographic information, including age, sexual orientation, gender identity, race/ethnicity, education, household income, living arrangements, and healthcare access. Demographic characteristics were self-reported, including age, gender identity (man, woman, transgender men, or intersex), and sexual orientation (heterosexual, gay or lesbian, bisexual, queer, or questioning), race (white, black, Asian, American Indian/Native Alaskan, and other), ethnicity (Hispanic or Latino), education ($40,000)<$40,0001.730.75–4.000.1970.730.28–1.880.5155.211.93–14.04<0.001***2.800.94–7.700.0622.700.98–7.070.055Healthcare discrimination (ref: none)Any discrimination1.630.76–3.480.2092.250.89–5.670.08416.194.25–61.63<0.001***7.902.10–29.000.002**4.171.44–12.080.008**Model χ2 (df)26.29 (6)***25.01 (6)***65.75 (6)***40.95 (6)***47.61 (6)***Cox & Snell R20.1420.1360.3190.2130.243Nagelkerke R20.1920.1990.4640.3290.359AOR, adjusted odds ratio; CI, confidence interval. All predictors entered simultaneously in each model (N = 171 per model; listwise deletion for missing predictor data). Model χ2, omnibus likelihood-ratio test of the full model against the intercept-only model (df = 6 for all models). Cox & Snell R2 and Nagelkerke R2 are reported as measures of model fit, as specified in the methods (data analysis). *p < 0.05; **p < 0.01; ***p < 0.001. Multivariate logistic regression models examining social determinants of health outcomes among individuals living with Parkinson’s disease. AOR, adjusted odds ratio; CI, confidence interval. All predictors entered simultaneously in each model (N = 171 per model; listwise deletion for missing predictor data). Model χ2, omnibus likelihood-ratio test of the full model against the intercept-only model (df = 6 for all models). Cox & Snell R2 and Nagelkerke R2 are reported as measures of model fit, as specified in the methods (data analysis). *p < 0.05; **p < 0.01; ***p < 0.001. Discussion Health disparities among persons living with Parkinson’s disease When examining several social determinants of health, younger age, identifying as a person of color, and experiencing healthcare discrimination emerged as the most consistent predictors of poorer physical, mental and social health outcomes. Within this broader context, LGBTQ+ individuals living with PD reported a higher burden of health and social challenges, including more severe motor impairment and loneliness, than their non-LGBTQ+ counterparts. LGBTQ+ individuals living with PD also experienced a greater burden of comorbidities, including higher rates of anxiety and HIV, despite being approximately 5.3 years younger on average than their non-LGBTQ+ individuals living with PD. These findings suggest that LGBTQ+ individuals living with PD may face disproportionate health challenges that extend beyond the age differences. Additionally, younger participants (<65 years) reported worse physical, mental, and social health outcomes than older participants, which may be a pattern that seems counterintuitive given the progressive nature of PD. One possible explanation is that younger participants had early-onset PD or more rapidly progressing PD, which could contribute to worse health outcomes. However, we are unable to examine these aspects given that our study did not collect data on disease severity, duration, or stage. Several other explanations should also be considered. First, survivor bias may have influenced our findings, as older participants who were able to complete a 45-min telephone survey may represent a healthier subset of older adults living with PD. Second, younger participants may have been more likely to have early-onset PD, which has been associated with distinct clinical trajectories and greater psychosocial burden (2, 23). Third, younger individual living with PD may be more likely to be balancing employment and caregiving responsibilities, creating additional stressors that could adversely affect mental and social health. Finally, differences in healthcare-seeking behavior, symptom awareness, or expectations regarding health across age groups may also explain these differences. Future longitudinal studies that include detailed clinical measures are needed to better disentangle the contributions of age, disease duration, disease severity, and social factors to these observed differences. These disparities may reflect the cumulative effects of minority stress, barriers to accessing social and economic resources, and broader social determinants of health that may shape long-term PD-related outcomes. Consistent with our findings, studies have found that LGBTQ+ older adults face physical, mental, and social health disparities (24, 25). Although few studies have examined differences in physical and mental health between LGBTQ+ and non-LGBTQ+ individuals living with PD, research with LGBTQ+ aging populations living with similar neurodegenerative diseases, such as dementia and cognitive decline, have found greater physical and mental health disparities (26, 27). This may suggest that health disparities observed among LGBTQ+ aging populations may extend across multiple neurodegenerative diseases, including PD. Sociodemographic characteristics The LGBTQ+ group in our sample was, on average, 5.3 years younger than the non-LGBTQ+ group and differed significantly in terms of sex assigned at birth and marital status. Although age, marital status, and other sociodemographic characteristics were included as covariates in our multivariable models, residual confounding could not be ruled out and the observed disparities between LGBTQ+ and non-LGBTQ+ participants may partly reflect these underlying demographic differences rather than LGBTQ+ identity. Matching strategies (e.g., age-matching or propensity score matching) were not employed given our modest sample size, which would have limited statistical power for both the matched analysis and the broader examination of social determinants of health that was a central aim of this study. Future studies with larger, matched, or longitudinal samples are needed to more precisely disentangle the independent contribution of LGBTQ+ status from correlated demographic factors. Healthcare discrimination as a driver of poor outcomes Our study also found that LGBTQ+ individuals living with PD reported greater healthcare discrimination than non-LGBTQ+ individuals living with PD. These findings are consistent with prior research showing that LGBTQ+ individuals living with PD experience more discrimination in healthcare settings, as well as greater social and economic disadvantages, including lower income and higher rates of unemployment, compared with older cisgender heterosexual men living with PD (11). These findings likely highlight the challenges LGBTQ+ individuals may face in managing a progressive neurodegenerative disease while navigating systemic barriers that can contribute to inequitable access to healthcare and support services. We found that healthcare discrimination was associated with moderate-to-severe loneliness, poorer health-related quality of life, and greater depressive symptoms. However, because of the cross-sectional design, these findings do not establish the temporal or causal direction of these associations. It is possible that experiences of healthcare discrimination are associated with poorer psychosocial outcomes, that individuals experiencing greater loneliness or depressive symptoms are more likely to perceive or report discrimination, or that these relationships are bidirectional. These findings align with prior research demonstrating that stigma and discrimination were associated with worse mental health outcomes, reduced quality of life, and lower overall wellbeing (28–30). There is a need for culturally responsive and inclusive healthcare that addresses discrimination, reduces stigma, and promotes mental health and quality of life among diverse populations living with PD. Social and structural determinants of physical and mental health Several social determinants of health were associated with a higher burden of PD-related physical, mental, and social health challenges. For instance, we found that younger age, identifying as a person of color, not being married/partnered, and reporting a lower income were associated with moderate to severe non-motor-related PD symptoms, loneliness, worse quality of life, and greater depressive symptoms. PD-related studies have mostly examined the role of social determinants of health on PD-related quality of life. These studies have found differences in quality of life based on age, education, gender, employment, income, marital status, social relationships/social support, and race/ethnicity (23, 31, 32). Depression and depressive symptoms are often elevated among individuals living with PD and among those with neurodegenerative diseases (33, 34). Similar to our study, other studies have found that age, marital status, and income were associated with depression among individuals living with PD (35). Our study found that LGBTQ+ individuals living with PD reported greater loneliness than non-LGBTQ+ individuals living with PD. Greater loneliness was also reported among individuals living with PD who identified as people of color, were unmarried, and had lower incomes. Although few studies have examined determinants of loneliness among individuals living with PD, one study found that social exclusion and material deprivation (i.e., lack of economic resources) were more common among individuals living with PD and were associated with poorer quality of life and mental and physical health (36). Effective care for persons living with PD requires moving beyond symptom management alone, toward an interdisciplinary approach that actively screens for comorbid conditions, addresses social isolation and loneliness, and provides culturally affirming care. LGBTQ+ communities remain largely absent from PD research, leaving significant gaps in our understanding of how best to support their care needs. Future research must prioritize the inclusion of LGBTQ+ persons living with in PD, with particular attention to the intersection of minority stress, chronic conditions, and social determinants of health shape disease outcomes. Limitations of the study While the current study revealed key factors associated with PD-related symptoms among diverse individuals living with Parkinson’s, several limitations should be considered. First, the study was cross-sectional and relied on a convenience sample. Participants were primarily recruited from Michael J. Fox Buddy Network, a free online peer support platform that connect members of the PD community. Despite our study revealing elevated rates of loneliness, these estimates may underestimate the extent of loneliness among the broader PD community, especially given many of our study participants had some level of connection to others living with PD through the Buddy Network. However, participants recruited through this network likely differ from the broader PD population in terms of their healthcare engagement, education, social support, digital literacy, community connectedness and willingness to disclose their LGBTQ+ identities. This also limits the external validity of our findings and results should be interpreted cautiously. Additionally, despite the current study revealing elevated rates of loneliness, these estimates may underestimate the extent of loneliness among the broader PD community, especially given many of our study participants had some level of connection to others living with PD through the Buddy Network. This likely limits the generalizability of our study findings to other populations living with PD. In addition, snowball sampling may have introduced self-selection bias, as individuals who are more engaged with the PD community and more willing to disclose their identity may be overrepresented in the sample. Moreover, findings may not be fully representative of the broader LGBTQ+ and non-LGBTQ+ communities living with PD. Our relatively small sample size also limited statistical power to examine differences among LGBTQ+ and racial/ethnic subgroups. Additionally, participants generally had high levels of education and income. Given that race/ethnicity and socioeconomic status are important social determinants of health, future research should prioritize recruitment strategies that engage socioeconomically and racial/ethnically diverse populations living with PD. Additionally, this study included numerous bivariate comparisons across demographic characteristics, health conditions, and PD-related outcomes. Because the study was exploratory and intended to generate hypotheses, we did not correct for multiple comparisons (e.g., Bonferroni). As a result, the risk of Type I error was increased, and some statistically significant associations may represent chance findings rather than true underlying relationships. Our results should be interpreted with caution and considered preliminary until replicated in other studies with predetermined hypotheses. It is also important to note that the discrimination measures used in this study did not distinguish among different forms of discrimination (e.g., based on sex, race/ethnicity, gender identity, or sexual orientation), limiting our ability to determine which types of discrimination are most strongly associated with PD-related symptoms. Finally, our survey did not collect clinician-verified or medical record-based clinical variables, such as disease duration, age at PD diagnosis, current medication regimen, levodopa equivalent daily dose, or Hoehn and Yahr disease stage. These are well-established predictors of symptom severity and functional impairment in PD, and their absence limit our ability to determine whether the disparities observed between LGBTQ+ and non-LGBTQ+ participants, as well as across other demographic characteristics, reflect differences in underlying disease severity, social determinants of health, or an interaction between these factors. Additionally, although our study focused on a priori social determinants of health, variable selection for the multivariable regression models was based on those that demonstrated significant bivariate associations. Given our modest sample size, this approach was intended to produce more parsimonious models and reduce the risk of overfitting. However, we acknowledge that this data-driven strategy may have excluded clinically or theoretically important confounders that did not reach statistical significance in unadjusted analyzes and is not a substitute for a priori confounder selection based on existing evidence. Consequently, our findings may be subject to residual confounding, limiting our ability to fully disentangle the relative contributions of disease severity and social determinants of health to the observed associations, and should be interpreted accordingly. Conclusion This study provides important insights into the role of social determinants of health in shaping the experiences of LGBTQ+ and non-LGBTQ+ individuals living with PD. Future research should prioritize larger and more diverse samples of individuals living with PD to better understand how factors such as discrimination influence symptom burden and disease trajectories. Additional research is also needed to examine the experiences of transgender and gender-diverse individuals, bisexual and queer populations, and people aging with both PD and HIV. Finally, efforts to address and reduce structural inequities are essential for improving healthcare experiences and outcomes among diverse populations living with PD. Without such efforts, disparities in health and wellbeing will likely persist among an already vulnerable population.